Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Incorporating Stepped Care Approach Into e-CBT for Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04747873
Recruitment Status : Recruiting
First Posted : February 10, 2021
Last Update Posted : April 14, 2021
Sponsor:
Information provided by (Responsible Party):
Dr. Nazanin Alavi, Queen's University

Brief Summary:
This randomized trial intervention will provide e-CBT for MDD through the Online Psychotherapy Tool (OPTT), a secure, cloud-based, digital mental health platform. Participants (age: 18-65 years) will be offered an e-CBT program tailored to MDD over 12 weeks to address their depressive symptoms. Participants will complete pre-designed modules and homework assignments while receiving personalized feedback and asynchronous interaction with a therapist through the platform. The content of the e-CBT modules is designed to mirror in-person standard CBT for MDD. There will be 12 weekly sessions that include approximately 30 slides each along with interactive content, delivered through OPTT. Using clinically validated symptomology questionnaires, the efficacy of the e-CBT program will be evaluated. Both groups will receive the 12-week e-CBT program with one group receiving the standard program. In the second arm, a stepped care approach can be implemented if deemed necessary by the care provider. This decision will be made if the participant has not shown improvement. Questionnaire data along with physiological data will be used to determine the decision.

Condition or disease Intervention/treatment Phase
Depression Major Depressive Disorder Depressive Symptoms Behavioral: e-CBT Behavioral: Stepped Care Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 110 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Participants will be randomized into 2 groups. One group will be given 12 weeks of e-CBT for depression. The other group will be given the same 12 weeks of e-CBT modules along with the possibility of additional attention if deemed necessary by the therapist.
Masking: Single (Participant)
Masking Description: Participants will not be told if they are in a stepped care approach or not. They will all be participating in the same e-CBT modules.
Primary Purpose: Treatment
Official Title: Investigating the Effectiveness of Incorporating a Stepped Care Approach Into Electronically-delivered CBT for Depression
Actual Study Start Date : April 7, 2021
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : February 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: e-CBT
12 weekly sessions with approximately 30 slides and interactive content, delivered through OPTT designed to mirror in-person standard CBT. Participants go through the content and complete homework at the end of the session. Homework is submitted through OPTT and reviewed by the therapist assigned to the participant, who will provide personalized feedback within three days of submission. Therapists have access to pre-designed session-specific feedback templates to use as a basic structure to write their feedback. By doing so, the time needed to respond to each patient is reduced and therefore the number of patients each therapist can handle increases. On average, developing this feedback takes a therapist 15-20 minutes per patient. In addition to the weekly feedback, participants have the option to message their therapist through the platform throughout the week regarding any questions or concerns they may have.
Behavioral: e-CBT
The focus of the sessions is placed on the connection between thoughts, behaviours, emotions, physical reactions, and the environment. We work on evaluating negative beliefs and thought processes and their relationship with depression. Our goal is to adjust the negative thinking so that participants can think about and adapt to the things that are happening to them. This allows them to adjust the way they behave and think about their problems in a way that is not as negative and replaces those thoughts and behaviours with potentially more realistic and productive ones. Participants will be offered e-CBT program over 12 weeks with approximately 30 slides in each module. Participants will complete pre-designed modules and homework assignments while receiving personalized feedback and asynchronous interaction with a therapist through the platform.

Experimental: e-CBT + Stepped Care

1 - Participant will receive message from assigned care provider on OPTT who check-in with them about strategies and techniques they have discussed and remind them of weekly homework due date.

2.- Participant will receive phone call from therapist who will check-in on them, remind them of therapy strategies, and verbally remind them of weekly homework due date.

3 - Participant will receive phone call from assigned care provider who will check-in on them, remind them of some therapy strategies and techniques and weekly session due date, and provide CBT summary of previously reviewed CBT concepts.

4 - articipant will receive video call (Microsoft Teams) from their therapist who will check-in on them, remind them of weekly session due date, and provide CBT content support to participant.

5 - Participant will receive CBT sessions in live video call (Microsoft Teams) with research psychiatrist involved in care.

Behavioral: e-CBT
The focus of the sessions is placed on the connection between thoughts, behaviours, emotions, physical reactions, and the environment. We work on evaluating negative beliefs and thought processes and their relationship with depression. Our goal is to adjust the negative thinking so that participants can think about and adapt to the things that are happening to them. This allows them to adjust the way they behave and think about their problems in a way that is not as negative and replaces those thoughts and behaviours with potentially more realistic and productive ones. Participants will be offered e-CBT program over 12 weeks with approximately 30 slides in each module. Participants will complete pre-designed modules and homework assignments while receiving personalized feedback and asynchronous interaction with a therapist through the platform.

Behavioral: Stepped Care
Stepped care procedure (see arm/group descriptions).




Primary Outcome Measures :
  1. Change in symptoms (Participant Health Questionnaire - 9 Item) [ Time Frame: Week 3, 6, 9, 12 ]
    Clinical standardized symptom questionnaire. Scale of 0-3, 3 being the worst.

  2. Change in symptoms (Quick Inventory of Depressive Symptoms) [ Time Frame: Week 1 ]
    Clinical standardized symptom questionnaire. Scale of 0-3, 3 being the worst.

  3. Change in quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire) [ Time Frame: Week 1, 6, 12 ]
    Clinical standardized symptom questionnaire. Scale of 1-5, 1 being the worst.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18-65 years at the start of the study
  • Diagnosis of major depressive disorder according to DSM-5 criteria
  • Competence to consent and participate
  • Ability to speak and read English
  • Consistent and reliable access to the internet

Exclusion Criteria:

  • Active psychosis
  • Acute mania
  • Severe alcohol or substance use disorder
  • Active suicidal or homicidal ideation
  • Currently receiving another form of psychotherapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04747873


Contacts
Layout table for location contacts
Contact: Nazanin Alavi, MD, FRCPC 6135443310 nazanin.alavitabari@kingstonhsc.ca

Locations
Layout table for location information
Canada, Ontario
Queen's University Recruiting
Kingston, Ontario, Canada, K7L 5G2
Contact: Nazanin Alavi, MD FRCPC    613-544-3310    nazanin.alavitabari@kingstonhsc.ca   
Principal Investigator: Nazanin Alavi, MD FRCPC         
Sponsors and Collaborators
Queen's University
Investigators
Layout table for investigator information
Principal Investigator: Nazanin Alavi, MD, FRCPC Queen's University
Layout table for additonal information
Responsible Party: Dr. Nazanin Alavi, Principal Investigator, Assistant Professor, Queen's University
ClinicalTrials.gov Identifier: NCT04747873    
Other Study ID Numbers: PSYC-247-21
First Posted: February 10, 2021    Key Record Dates
Last Update Posted: April 14, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: We will share results through conference presentations, journal publications, and workshops.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Time Frame: We plan to publish our protocol and statistical analysis plan during the course of the study.
Access Criteria: Participant identification information will always be kept confidential and only anonymized data will be used for the publication of results.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Dr. Nazanin Alavi, Queen's University:
Mental Health
Psychotherapy
Depression
Cognitive Behavioural Therapy
Electronic
Internet
Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Depressive Disorder
Depressive Disorder, Major
Behavioral Symptoms
Mood Disorders
Mental Disorders